Abbott Laboratories (ABT)
Return on total capital
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) (ttm) | US$ in thousands | 8,666,000 | 8,471,000 | 7,975,000 | 7,616,000 | 7,464,000 | 7,177,000 | 7,191,000 | 7,362,000 | 6,816,000 | 6,811,000 | 7,459,000 | 8,621,000 | 9,553,000 | 10,351,000 | 9,398,000 | 8,621,000 | 8,707,000 | 7,642,000 | 6,845,000 | 5,676,000 |
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 50,954,000 | 50,565,000 | 48,811,000 | 47,664,000 | 39,796,000 | 39,318,000 | 38,810,000 | 38,603,000 | 37,481,000 | 37,174,000 | 74,219,000 | 36,686,000 | 35,675,000 | 36,490,000 | 35,399,000 | 35,802,000 | 34,422,000 | 33,800,000 | 33,562,000 | 32,784,000 |
| Return on total capital | 17.01% | 16.75% | 16.34% | 15.98% | 18.76% | 18.25% | 18.53% | 19.07% | 18.19% | 18.32% | 10.05% | 23.50% | 26.78% | 28.37% | 26.55% | 24.08% | 25.29% | 22.61% | 20.40% | 17.31% |
September 30, 2025 calculation
Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $8,666,000K ÷ ($—K + $50,954,000K)
= 17.01%